文献速递心脏核医学

COVID-19感染后心肌灌注SPECT表现

Myocardial perfusion SPECT findings in postCOVID period.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-09-07

该研究比较了COVID-19感染后6个月内转诊行心肌灌注扫描(MPS)的患者与疫情前年龄性别匹配对照,发现研究组缺血报告率更高(p < 0.001),且无论MPS结果如何,冠状动脉造影(CAG)需求和治疗需求均更高(p = 0.006和p = 0.015);在MPS异常患者中同样如此(p = 0.008和p = 0.024),但在缺血患者中无差异(p = 0.29和p = 0.06)。结论认为COVID-19后晚期出现心血管症状时MPS是可靠方法。

要点

  • COVID-19感染后6个月内行MPS者缺血报告率显著高于疫情前对照(p < 0.001)。
  • 研究组CAG需求及治疗需求均高于对照(p = 0.006和p = 0.015)。
  • MPS异常者中CAG和治疗需求仍更高(p = 0.008和p = 0.024),缺血者中无差异。

核心结论

  • COVID-19感染后6个月内患者MPS缺血频率、接受CAG、支架植入或CABG及启动药物治疗均显著增加。
  • COVID-19后晚期出现心血管症状时MPS是可靠检查方法。

研究设计与样本

  • 研究组为2020年8月至2021年4月转诊行MPS且过去6个月内经PCR确诊有症状COVID-19感染史的患者。
  • 对照组为2019年1月至2019年9月疫情前随机选取的年龄性别匹配MPS患者。
  • 比较两组缺血频率、CAG及侵入性或药物治疗情况。

主要发现

  • 研究组缺血报告率高于对照组(p < 0.001)。
  • 无论MPS结果如何,研究组CAG需求(p = 0.006)和治疗需求(药物或侵入性干预,p = 0.015)均高于对照组。
  • MPS结果异常患者中CAG需求(p = 0.008)和治疗需求(p = 0.024)仍更高。
  • 缺血患者中CAG需求(p = 0.29)和治疗需求(p = 0.06)无显著差异。

临床怎么用

  • 对COVID-19感染后6个月内出现心血管症状的患者,可考虑行MPS评估心肌缺血。
  • MPS结果需结合临床评估,因研究组即使MPS无缺血也有更高的CAG和治疗需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate if (i) the risk of ischemia on myocardial perfusion scan (MPS), (ii) number of coronary angiographies (CAG) performed, and (iii) necessity for invasive (stent implantation or coronary artery bypass grafting (CABG)) or medical treatment increased in patients infected with COVID-19. METHODS: Patients who were referred to MPS between August 2020 and April 2021 with a history of active symptomatic COVID-19 infection (confirmed by PCR positivity) in the last 6 months were involved in the study group. Age-and gender-matched control group was composed of randomly chosen patients who attended for MPS between January 2019 and September 2019, before pandemic. Frequency of ischemia, CAG, and invasive or medical treatments were compared between groups. RESULTS: Ischemia was reported more frequently in the study group (p < 0.001). In clinical evaluation, regardless of the MPS results, the necessity for invasive evaluation with CAG and treatment (either medical therapy or invasive interventions) was higher in the study group (p = 0.006 and p = 0.015). It was also true for patients with abnormal MPS results (p = 0.008 and p = 0.024) but not for the patients with ischemia (p = 0.29 and p = 0.06). CONCLUSION: There exists a significant increase in the frequency of ischemia on MPS, undergoing CAG, stent implantation or CABG, and initiation of medical therapy in patients with a history of COVID-19 infection in the last 6 months. MPS is a reliable method in patients who present with cardiovascular symptoms in the late COVID period.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Araz M, Soydal Ç, Sütçü G, et al. Myocardial perfusion SPECT findings in postCOVID period. Eur J Nucl Med Mol Imaging. 2021. PMID: 34490492. doi:10.1007/s00259-021-05552-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。